US 12208099
Combination therapies
granted A61KA61K31/428A61K31/4375
Quick answer
US patent 12208099 (Combination therapies) held by Mirati Therapeutics, Inc. expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/428, A61K31/4375, A61K31/44, A61K31/4985